10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 306 filers reported holding 10X GENOMICS INC in Q4 2020. The put-call ratio across all filers is 0.38 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $297 | -6.9% | 7,193 | +26.0% | 0.00% | 0.0% |
| Q2 2023 | $319 | -5.1% | 5,707 | -5.4% | 0.00% | 0.0% |
| Q1 2023 | $336 | +22.6% | 6,030 | -19.9% | 0.00% | 0.0% |
| Q4 2022 | $274 | -99.9% | 7,528 | -0.4% | 0.00% | 0.0% |
| Q3 2022 | $215,000 | -37.3% | 7,558 | -0.3% | 0.00% | 0.0% |
| Q2 2022 | $343,000 | -51.3% | 7,582 | -18.2% | 0.00% | -50.0% |
| Q1 2022 | $704,000 | -49.8% | 9,266 | -1.6% | 0.00% | -33.3% |
| Q4 2021 | $1,402,000 | +2.9% | 9,413 | +0.5% | 0.00% | 0.0% |
| Q3 2021 | $1,363,000 | -36.7% | 9,366 | -14.8% | 0.00% | -40.0% |
| Q2 2021 | $2,152,000 | +8.1% | 10,992 | -0.1% | 0.01% | -16.7% |
| Q1 2021 | $1,990,000 | +36.4% | 10,999 | +6.7% | 0.01% | +50.0% |
| Q4 2020 | $1,459,000 | +16.3% | 10,306 | +2.4% | 0.00% | 0.0% |
| Q3 2020 | $1,255,000 | – | 10,066 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $174,178,000 | 96.89% |
| Foresite Capital Management II, LLC | 2,253,528 | $407,889,000 | 93.76% |
| Foresite Capital Management I, LLC | 1,000,000 | $181,000,000 | 91.29% |
| 12 West Capital Management LP | 1,922,000 | $347,882,000 | 16.58% |
| FINANCIAL CONSULATE, INC | 158,758 | $28,735,000 | 11.65% |
| Meritech Capital Associates V L.L.C. | 2,123,356 | $384,327,000 | 9.48% |
| Andar Capital Management HK Ltd | 48,000 | $8,688,000 | 9.16% |
| JS Capital Management LLC | 517,256 | $93,623,000 | 4.84% |
| Ground Swell Capital, LLC | 3,713 | $672,000 | 2.17% |
| Renaissance Capital LLC | 79,518 | $14,393,000 | 2.13% |